ULTRALIFE CORP — Director's Dealing 2015

Oct 9, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ULTRALIFE CORP (ULBI)
CIK: 0000875657
Period of Report: 2015-10-08

Reporting Person: POPIELEC MICHAEL D (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-10-08	Common Stock, $.10 par value	M	39147	$0.00	Acquired	260288	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-10-08	Restricted Stock Units	$0.00	J	60000	Disposed	2020-12-30	Common Stock $.10 par value (60000)	Direct

Footnotes

F1: Represents the conversion of 60,000 restricted stock units previously awarded to Michael D. Popielec on June 4, 2013 upon the vesting of such restricted stock units on October 8, 2015. The Company retained 20,853 shares of common stock issuable to Mr. Popielec in satisfaction of his individual minimum statutory withholding obligation calculated at $5.8617 per share, the volume-weighted average price per share on the vesting date.